Table 3.

Key strengths and weaknesses of current web-based clinical decision tools.

Strengths

Weaknesses

•Validation of the tools in different populations •Described the health condition or problem •Described the decisions that need to be made •Stated target audience – whether the tool was designed for patients or providers •Provided user guidance and incorporated non-medical language •Provided citations and author credentials

•Missing key parameters such as comorbidities and race •Advantages and disadvantages of options were not adequately described •Lack of information on the level of uncertainty around the estimates •Inadequate data on the ‘Readability’ of the web-tools using standard scales •Limited clinical trials on user outcomes •Lack of tools integrating multiple treatment modalities •No tools for newer breast cancer treatments (e.g., Immunotherapy)